Spirometry

2,362 views 33 slides Mar 20, 2021
Slide 1
Slide 1 of 33
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33

About This Presentation

Test to Check the lung volume capacity. It is also known as Pulmonary Function Test. Spirometery is also used to increase the Lung capacity and Respiratory Muscle Strength. This device also used as a Breathing training exercise and Breathing resistance Exercise.


Slide Content

Spirometery Dr. Prashant Kaushik BPT, MPT (Sports) Assistant Professor Kailash institute of Nursing And Paramedical Science

D E F I N I T ION  Spirometry is derived from the Latin words SPIRO (to breathe) and METER (to measure).  Spirometry is a method of assessing lung function by measuring the volume of air that the patient can expel from the lungs after a maximal inspiration. a method of assessing lung function

HISTORY The spirometer was originally invented in the 1840’s by John Hutchinson an English surgeon. The volume of exhaled air from fully inflated lungs could accurately be measured by exhaling into a tube leading into the bucket. Helped in measurement of Vital Capacity. In 1950 Dr. Tiffeneau of France introduced the forced measurement of air volume during a given time frame, i.e., forced expiratory volume in 1 second, FEV1. Wright B.M. and McKerrow C.B. introduced the peak flow meter in 1959. In 2008, Advanced Medical Engineering developed the world's first wireless spirometer with 3D Tilt-Sensing for far greater quality control in the testing environment.

The First S p i r om e ter

INDICATIONS Spirometry is the best way of detecting the presence of airway obstruction and making a definitive diagnosis of asthma and COPD. In COPD its uses are Measure airflow obstruction to help make a definitive diagnosis of COPD. Confirm presence of airway obstruction. Assess severity of airflow obstruction in COPD. Detect airflow obstruction in smokers who may have few or no symptoms. Monitor disease progression in COPD. Assess one aspect of response to therapy. Assess prognosis (FEV 1 ) in COPD. Perform pre-operative assessment.

ADDITIONAL USES  Make a diagnosis and assess severity in a range of other respiratory conditions  Distinguish between obstruction and restriction as causes of breathlessness  Screen workforces in occupational environments  Assess fitness to dive  Perform pre-employment screening in certain professions

Types of Spirometers  Bellows spirometers: Measure volume ; mainly in lung function units  Electronic desk top spirometers: Measure flow and volume with real time display  Small hand-held spirometers: Inexpensive and quick to use but no print out

Volume Measuring Spirometer

Flow Measuring Spirometer

Desktop Electronic Spirometers

Small Hand-held Spirometers

LUNG VOLUMES AND CAPACITIES Tidal volume : that volume of air moved into or out of the lungs during quiet breathing Inspiratory reserve volume : the maximal volume that can be inhaled from the end-inspiratory level Inspiratory capacity : the sum of IRV and TV Expiratory reserve volume : the maximal volume of air that can be exhaled from the end-expiratory position Vital capacity : the volume of air breathed out after the deepest inhalation. Total lung capacity : the volume in the lungs at maximal inflation, the sum of VC and RV. Residual volume : the volume of air remaining in the lungs after a maximal exhalation

Standard Spirometric Indicies FEV 1 - Forced expiratory volume in one second: The volume of air expired in the first second of the blow FVC - Forced vital capacity: The total volume of air that can be forcibly exhaled in one breath FEV 1 /FVC ratio: The fraction of air exhaled in the first second relative to the total volume exhaled FEV 6 – Forced expired volume in six seconds: Often approximates the FVC. Easier to perform in older and COPD patients but role in COPD diagnosis remains under investigation MEFR – Mid-expiratory flow rates: Derived from the mid portion of the flow volume curve but is not useful for COPD diagnosis

PROCEDURE

Withholding Medications Before performing spirometry, withhold: Short acting β 2 -agonists for 6 hours Long acting β 2 -agonists for 12 hours Ipratropium for 6 hours Tiotropium for 24 hours Optimally, subjects should avoid caffeine and cigarette smoking for 30 minutes before performing spirometry

Performing Spirometry - Preparation Explain the purpose of the test and demonstrate the procedure Record the patient’s age, height and gender and enter on the spirometer Note when bronchodilator was last used Have the patient sitting comfortably Loosen any tight clothing Empty the bladder beforehand if needed

Breath in until the lungs are full Hold the breath and seal the lips tightly around a clean mouthpiece Blast the air out as forcibly and fast as possible. Provide lots of encouragement! Continue blowing until the lungs feel empty

 Watch the patient during the blow to assure the lips are sealed around the mouthpiece  Check to determine if an adequate trace has been achieved  Repeat the procedure at least twice more until ideally 3 readings within 100 ml or 5% of each other are obtained

Spirometry - Possible Side Effects  Feeling light-headed  Headache  Facial redness  Fainting: reduced venous return or vasovagal attack (reflex)  Transient urinary incontinence Spirometry should be avoided after recent heart attack or stroke

Spirogram Patterns Normal Obstructive Restrictive Mixed Obstructive and Restrictive

NORMAL SPIROGRAM

NORMAL FLOW-VOLUME CURVE

ABNORMAL FLOW-VOLUME PATTERNS

Diseases Associated With Airflow Obstruction  COPD  Asthma  Bronchiectasis  Cystic Fibrosis  Post-tuberculosis  Lung cancer (greater risk in COPD)  Obliterative Bronchiolitis

Spirometric Diagnosis of COPD  COPD is confirmed by post–bronchodilator FEV 1 /FVC < 0.7  Post-bronchodilator FEV 1 /FVC measured 15 minutes after 400µg salbutamol or equivalent

Bronchodilator Reversibility Testing  Provides the best achievable FEV 1 (and FVC)  Helps to differentiate COPD from asthma Must be interpreted with clinical history - neither asthma nor COPD are diagnosed on spirometry alone

Bronchodilator Reversibility Testing  Can be done on first visit if no diagnosis has been made  Best done as a planned procedure: pre- and post-bronchodilator tests require a minimum of 15 minutes  Post-bronchodilator only saves time but does not help confirm if asthma is present  Short-acting bronchodilators need to be withheld for at least 4 hours prior to test

Bronchodilator Reversibility Testing Bronchodilator* Dose FEV 1 before and after Salbutamol 200 – 400 µg via large volume spacer 15 minutes Terbutaline 500 µg via T urb o hale r ® 15 minutes Ipratropium 160 µg** via spacer 45 minutes

Bronchodilator Reversibility Testing in COPD

POST BRONCHODILATOR SPIROMETRY

Thank You